2014
DOI: 10.1002/ijc.29130
|View full text |Cite
|
Sign up to set email alerts
|

p16INK4a/Ki‐67 co‐expression specifically identifies transformed cells in the head and neck region

Abstract: p16INK4a immunohistochemical overexpression is an overall reliable surrogate marker of human papillomavirus (HPV)-associated head and neck squamous cell carcinomas (HNSCC High-risk human papillomavirus (HR-HPV)-induced head and neck squamous cell carcinomas (HNSCC) represent an individual tumor entity with biological and clinical characteristics that distinguish them from the classical smoking-or alcohol-related HNSCC. 1,2 The reliable identification of HPVinduced HNSCC will become important for HPV-stratified… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
49
1
2

Year Published

2014
2014
2020
2020

Publication Types

Select...
9

Relationship

5
4

Authors

Journals

citations
Cited by 50 publications
(53 citation statements)
references
References 43 publications
1
49
1
2
Order By: Relevance
“…For detection, DNA was extracted from variable numbers of FFPE tissue sections depending on the tissue size (10 µm sections, approximately corresponding to 10 mm × 10 mm tumor tissue) using the DNeasy Blood & Tissue Kit by Qiagen, Hilden, Germany, according to the manufacturer’s instructions. Extracted DNA was analyzed for mucosal high-risk HPV DNA and HPV genotypes (16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68, 73, and 82) by PCR optimized for DNA extracted from FFPE tissue, followed by bead-based hybridization (Luminex Technology, Multimetrix, Progen, Heidelberg), as described previously (20, 21). HPV-DNA contamination protection steps (e.g., new microtome blades for every block, separated pre- and post-PCR areas) were applied and appropriate controls (tissue-free paraffin blocks, water controls) were processed to monitor potential HR–HPV DNA contamination.…”
Section: Methodsmentioning
confidence: 99%
“…For detection, DNA was extracted from variable numbers of FFPE tissue sections depending on the tissue size (10 µm sections, approximately corresponding to 10 mm × 10 mm tumor tissue) using the DNeasy Blood & Tissue Kit by Qiagen, Hilden, Germany, according to the manufacturer’s instructions. Extracted DNA was analyzed for mucosal high-risk HPV DNA and HPV genotypes (16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68, 73, and 82) by PCR optimized for DNA extracted from FFPE tissue, followed by bead-based hybridization (Luminex Technology, Multimetrix, Progen, Heidelberg), as described previously (20, 21). HPV-DNA contamination protection steps (e.g., new microtome blades for every block, separated pre- and post-PCR areas) were applied and appropriate controls (tissue-free paraffin blocks, water controls) were processed to monitor potential HR–HPV DNA contamination.…”
Section: Methodsmentioning
confidence: 99%
“…Extracted DNA was analyzed for mucosal high risk HPV-DNA and HPV genotypes (16,18,31,33,35,39,45, 51, 52, 56, 58, 59, 68, 73 and 82) by PCR optimized for DNA extracted from FFPE tissue, followed by bead-based hybridization (Luminex technology, Multimetrix, Progen, Heidelberg), as described previously. 17,18 HPV-DNA contamination protection steps (e.g., new microtome blades for every block, separated pre and post PCR areas) were applied and appropriate controls (tissue-free paraffin blocks, water-controls) were processed to monitor potential high risk HPV-DNA contamination. Amplification of b-globin was used to ensure DNA integrity.…”
Section: Hpv-dna Genotypingmentioning
confidence: 99%
“…Without p16 Ink4a there is inappropriate cell division and cell proliferation, which is why it is not surprising to find our immortalized cancer cell lines lacking p16 Ink4a . However, p16 Ink4a overexpression is sometimes used as a surrogate marker for high-risk-HPV-associated HNSCC (24,41,42). This is because the E7 HPV oncogene protein will induce p16 Ink4a expression.…”
Section: Discussionmentioning
confidence: 99%